Thermo Fisher Scientific announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant.
The company said the panel includes a customizable menu of real-PCR genotyping assays to identify known SARS-COV-2 variants in just over an hour.
Labs can choose from a menu of over 50 known mutations of SARS-CoV-2 to build their unique panel, which is designed to be highly scalable, and run up to several hundred samples to monitor for one or multiple mutations simultaneously.
